Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors.
about
Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonistThe pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function.The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.Biphasic effect of curcumin on morphine tolerance: a preliminary evidence from cytokine/chemokine protein array analysis.Modeling gene-by-environment interaction in comorbid depression with alcohol use disorders via an integrated bioinformatics approach.'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation.Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production.Lysosomotropic drugs inhibit maturation of transforming growth factor-beta.Soluble FasR ligand-binding domain: high-yield production of active fusion and non-fusion recombinant proteins using the baculovirus/insect cell system.Attenuation of inflammatory events in human intervertebral disc cells with a tumor necrosis factor antagonist.Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier.Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF beta 1 in semen.Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis.Human H-kininogen is a ferritin-binding protein.Tetrasomy 15q26: a distinct syndrome or Shprintzen-Goldberg syndrome phenocopy?
P2860
Q24656182-3FAE291C-B711-4B82-915C-3A874AA01485Q34071289-34DC61A0-A642-4A78-9D75-2251775FD1BDQ34340452-7FF8A49E-3C4D-4C13-9974-A13F7026B491Q35149088-5346251D-1D0A-440A-855E-5648F81B0152Q36900634-FBC3DA0F-C2F5-4A12-ACA3-4853643A792EQ36990620-E4C86A06-BB67-4BF9-B5F1-7DFF2C010458Q39747986-44F727E2-91C9-4FB0-81D6-ED97D488DA67Q39924024-FE76197B-DDA0-4E29-BCC4-54AA3C327F75Q39945344-22F440B6-CF9B-4C99-ADFD-DC6E88EEC4D7Q42060857-2ABC2A8A-9EE8-41FB-871B-B17248A7C00FQ42206619-08B9A220-979B-4C9B-BB15-0D424A0FE365Q42559841-2DA284F3-3F92-4600-A371-687D01AF59E3Q43240520-6B84E79B-9485-44A6-B023-FD8347D343FEQ45413409-7E0C5BCE-843D-4EC2-900A-7D472905FF07Q54546044-65544E19-0556-4DC3-AB70-582E6D39A22CQ56320834-C1A4E329-7B64-43EF-AB4A-B7BCB8882328
P2860
Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Mapping the domain(s) critical ...... or-alpha to its two receptors.
@en
type
label
Mapping the domain(s) critical ...... or-alpha to its two receptors.
@en
prefLabel
Mapping the domain(s) critical ...... or-alpha to its two receptors.
@en
P2093
P2860
P356
P1476
Mapping the domain(s) critical ...... or-alpha to its two receptors.
@en
P2093
P2860
P304
P356
10.1074/JBC.270.6.2874
P407
P577
1995-02-01T00:00:00Z